DLDi Lu

Di Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Di Lu has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Oguz Kanca

    Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, TX, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (TCH), Houston, TX, USA

    2 shared publications
  • Paul C. Marcogliese

    Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences University of Manitoba Winnipeg Manitoba Canada

    2 shared publications
  • Undiagnosed Diseases Network

    2 shared publications
  • Alex J Ho

    Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX, USA; Advanced Technology Core for Macromolecular X-ray Crystallography, Baylor College of Medicine, Houston, TX, USA

    1 shared publication
  • Angelina Gaspero

    Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, TX, USA

    1 shared publication
  • Audrey E. Christiansen

    Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, USA

    1 shared publication

Latest Publications

  • Open Access

    Uncovering Phenotypic Expansion in AXIN2-Related Disorders through Precision Animal Modeling

    by Nathalie M Aceves-Ewing, Denise G Lanza, Paul C Marcogliese, Di Lu, Chih-Wei Hsu, Hirokazu Hashimoto, Matthew Gonzalez, Audrey E Christiansen, Tara L Rasmussen, Alex J Ho, et al.

  • Open Access

    Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling

    by Paul C. Marcogliese, Debdeep Dutta, Shrestha Sinha Ray, Nghi D. P. Dang, Zhongyuan Zuo, Yuchun Wang, Di Lu, Fatima Fazal, Thomas A. Ravenscroft, Hyunglok Chung, et al.

    De novo truncations in Interferon Regulatory Factor 2 Binding Protein Like ( IRF2BPL ) lead to severe childhood-onset neurodegenerative disorders. To determine how loss of IRF2BPL causes neural dysfunction, we examined its function in Drosophila and zebrafish. Overexpression of either IRF2BPL or Pits , the Drosophila ortholog, represses Wnt transcription in flies. In contrast, neuronal depletion of Pits leads to increased wingless ( wg ) levels in the brain and is associated with axonal loss, whereas inhibition of Wg signaling is neuroprotective. Moreover, increased neuronal expression of wg in flies is sufficient to cause age-dependent axonal loss, similar to reduction of Pits. Loss of irf2bpl in zebrafish also causes neurological defects with an associated increase in wnt1 transcription and downstream signaling. WNT1 is also increased in patient-derived astrocytes, and pharmacological inhibition of Wnt suppresses the neurological phenotypes. Last, IRF2BPL and the Wnt antagonist, CKIα, physically and genetically interact, showing that IRF2BPL and CkIα antagonize Wnt transcription and signaling.